As we move forward, research must move beyond demonstrating that HCV and HIV
infections can be successfully treated among IDUs. There is clear evidence that this is both …

BACKGROUND: Illicit drug users account for the majority of cases of HCV infection in the
developed world, but few have received treatment. METHODS: We evaluated barriers to …

The demonstration that antiretroviral treatment is effective for the prevention of human
immunodeficiency virus (HIV) transmission has important implications for HCV prevention …

Objectives We evaluated assessment and treatment for hepatitis C virus (HCV) among illicit
drug users accepting referral to a weekly HCV peer-support group at a multidisciplinary …

Abstract Introduction and Aims. Uptake of treatment for hepatitis C virus (HCV) infection
among people who inject drugs is low. Further understanding is required of the relationship …

Illicit opioid use in Canada and elsewhere increasingly involves a variety of opioids and non-
injection routes of administration. Injection and non-injection opioid users tend to differ in …

This study investigated the role of psychological variables and judicial problems in treatment
retention for a low-threshold methadone program in Montreal, Canada. Logistic regression …

BACKGROUND: To analyze self-reported prevalence of HCV and HIV in a sample of
socially excluded injecting drug users, as well as factors associated with the presence of …

Background Little is known regarding barriers to hepatitis C virus (HCV) treatment among
people who inject drugs (PWID) in low-resource settings, particularly in the era of direct …

Some 300,000 individuals are infected with the hepatitis C virus (HCV) in Canada. HCV
infection is associated with major morbidity, mortality and health care costs; these indicators …